Skip to main content
Log in

Shared medical decision-making: A new paradigm for behavioral medicine—1997 presidential address

  • Published:
Annals of Behavioral Medicine

Abstract

Different conceptual models lead to different health care choices. The traditional biomedical model emphasizes identification of pathology (diagnosis) and remediation of these biological deficits (treatment). An alternative approach, known as the outcomes model, focuses attention on the outcomes of health care. Specifically, health care is regarded as effective only if it extends life or if it improves quality of life. Indices that combine life expectancy and life quality can be used to monitor the benefits of health care. According to the traditional model, medical care is effective if it improves a clinical indicator (i.e. reduces blood pressure, decreases tumor size, etc.). According to the outcomes model, treatments are not advocated unless they improve general outcomes. There are circumstances in which clinical indicators improve but general outcomes remain the same or get worse. Data on the detection and treatment of prostate cancer are used to illustrate how these models might lead to different treatment decisions. According to the traditional model, aggressive screening and treatment of prostate cancer should be advocated because more cases are detected early and more tumors are removed. According to the outcomes model, net quality-adjusted life may be reduced rather than enhanced with screening. Shared medical decision-making is an outgrowth of the outcomes model. Using these methods, patients and providers integrate the best scientific evidence on treatment efficacy with patient preferences for outcomes. Often shared decision-making leads to reductions in the use of medical procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brook RH, Lohr KN: Monitoring quality of care in the Medicare program. Two proposed systems.Journal of the American Medical Association. 1987,258:3138–3141.

    Article  PubMed  CAS  Google Scholar 

  2. Kaplan RM: The Ziggy Theorem: Toward an, outcomes-focused health psychology.Health Psychology. 1994,13:451–460.

    Article  PubMed  CAS  Google Scholar 

  3. Ware JE Bayliss MS, Rogers WH, Kosinski M, Tarlov AR: Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study.Journal of the American Medical Association. 1996,276:1039–1047.

    Article  PubMed  Google Scholar 

  4. Holman HR: Thought barriers to understanding rheumatic diseases.Arthritis and Rheumatism. 1994,37:1565–1572.

    Article  PubMed  CAS  Google Scholar 

  5. Cinciripini PM, Hecht SS, Henningfield JE, Manley MW, Kramer BS: Tobacco addiction: Implications for treatment and cancer prevention.Journal of the National Cancer Institute. 1997,89:1852–1867.

    Article  PubMed  CAS  Google Scholar 

  6. Wistuba II, Behrens C, Milchgrub S, et al: Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.Oncogene. 1999,18(3):643–650.

    Article  PubMed  CAS  Google Scholar 

  7. Eysenck HJ, Grossarth-Maticek R, Everitt B: Personality, stress, smoking, and genetic predisposition as synergistic risk factors for cancer and coronary heart disease.Integrated Physiology and Behavioral Science. 1991,26:309–322.

    Article  CAS  Google Scholar 

  8. U.S Office on Smoking and Health:Smoking and Health, A National Status Report: A Report to Congress (2nd Edition), DHHS Publication No. (CDC) 90-8416. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, 1990.

    Google Scholar 

  9. McGinnis JM, Foege WH: Actual causes of death in the United States.Journal of the American Medical Association. 1993,270: 2207–2212.

    Article  PubMed  CAS  Google Scholar 

  10. Eddy DM: Clinical decision-making: From theory to practice. Benefit language: Criteria that will improve quality while reducing costs.Journal of the American Medical Association. 1996,275:650–657.

    Article  PubMed  CAS  Google Scholar 

  11. Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW: Interobserver variability in coronary angiography.Circulation. 1976,53:627–632.

    PubMed  CAS  Google Scholar 

  12. Detre KM, Wright E, Murphy ML, Takaro T: Observer agreement in evaluating coronary angiograms.Circulation. 1975,52:979–986.

    PubMed  CAS  Google Scholar 

  13. Schnitt SJ, Connolly JL, Tavassoli FA, et al: Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.American Journal of Surgical Pathology. 1992,16:1133–1143.

    Article  PubMed  CAS  Google Scholar 

  14. Wennberg JE:The Dartmouth Atlas of Health Care in the United States. Hanover, NH: Trustees of Dartmouth College, 1998.

    Google Scholar 

  15. Wennberg JE, Freeman JL, Shelton RM, Bubolz TA: Hospital use and mortality among Medicare beneficiaries in Boston and New Haven.New England Journal of Medicine. 1989,321(17):1168–1173.

    PubMed  CAS  Google Scholar 

  16. Fisher ES, Wennberg JE, Stukel TA, Sharp SM: Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven.New England Journal of Medicine. 1994,331:989–995.

    Article  PubMed  CAS  Google Scholar 

  17. Kaplan RM: Behavior as the central outcome in health care.American Psychologist. 1990,45:1211–1220.

    Article  PubMed  CAS  Google Scholar 

  18. Kaplan RM, Anderson JP: The general health policy model. An integrated approach. In Spilker B (ed),Quality of Life and Pharmacoeconomics in Clinical Trials. New York: Raven, 1996, 309–322.

    Google Scholar 

  19. Kaplan RM:Hippocratic Predicament: Affordability, Access, and Accountability in Health Care. San Diego, CA: Academic Press, 1993.

    Google Scholar 

  20. Kaplan RM: Application of a general health policy model in the American health care crisis.Journal of the Royal Society of Medicine. 1993,86:277–281.

    PubMed  CAS  Google Scholar 

  21. Kaplan RM: An outcomes-based model for directing decisions in women's health care.Clinical Obstetrics and Gynecology. 1994,37:192–206.

    Article  PubMed  CAS  Google Scholar 

  22. Kaplan RM: Decisions about prostate cancer screening in managed care.Current Opinion in Oncology. 1997,9:480–486.

    PubMed  CAS  Google Scholar 

  23. Siegel JE, Weinstein MC, Russell LB, Gold MR Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.Journal of the American Medical Association. 1996,276:1339–1341.

    Article  PubMed  CAS  Google Scholar 

  24. Torrance GW, Feeny DH, Furlong WJ, et al: Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2.Medical Care. 1996,34:702–722.

    Article  PubMed  CAS  Google Scholar 

  25. Gold MR, Siegel JE, Russel LB, Weinstein MC:Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.

    Google Scholar 

  26. Field MJ, Gold MR:Summarizing Population Health: Directions for the Development and Application of Population Metric. Washington, DC: National Academy Press, 1998.

    Google Scholar 

  27. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study.Lancet. 1997,349:1498–1504.

    Article  PubMed  CAS  Google Scholar 

  28. Verrilli D, Welch HG: The impact of diagnostic testing on therapeutic interventions.Journal of the American Medical Association. 1996,275:1189–1191.

    Article  PubMed  CAS  Google Scholar 

  29. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP: A prospective study of venous thromboembolism after major trauma.New England Journal of Medicine. 1994,331:1601–1606.

    Article  PubMed  CAS  Google Scholar 

  30. Kornick J, Trefelner E, McCarthy S, et al: Meniscal abnormalities in the asymptomatic population at MR imaging.Radiology. 1990,177:463–465.

    PubMed  CAS  Google Scholar 

  31. Jensen MC, Brant-Zawadzki MN, Obuchowski N, et al: Magnetic resonance imaging of the lumbar spine in people without back pain.New England Journal of Medicine. 1994,331:69–73.

    Article  PubMed  CAS  Google Scholar 

  32. Fisher ES, Welch HG: Avoiding the unintended consequences of growth in medical care: How might more be worse?Journal of the American Medical Association. 1999,281(5):4454–4463.

    Article  Google Scholar 

  33. National Cancer Act. Public Law 99-158. 99th Congress, 1971.

  34. Bailar JC, Gornik HL: Cancer undefeated.New England Journal of Medicine. 1997,336:1569–1574.

    Article  PubMed  Google Scholar 

  35. Nicod P, Gilpin EA, Dittrich H, et al: Trends in use of coronary angiography in subacute phase of myocardial infarction.Circulation. 1991,84:1004–1015.

    PubMed  CAS  Google Scholar 

  36. Tu JV, Pashos CL, Naylor CD, et al: Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada.New England Journal of Medicine. 1997,336:1500–1505.

    Article  PubMed  CAS  Google Scholar 

  37. Tosteson AN, Weinstein MC, Hunink MG, et al: Cost-effectiveness of population-wide educational approaches to reduce serum cholesterol levels.Circulation. 1997,95:24–30.

    PubMed  CAS  Google Scholar 

  38. Welch HG, Black WC: Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: How much more breast cancer can we find?Annals of Internal Medicine. 1997,127:1023–1028.

    PubMed  CAS  Google Scholar 

  39. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK: Cancer incidence and mortality, 1973–1995: A report card for the U.S.Cancer. 1998,82:1197–1207.

    Article  PubMed  CAS  Google Scholar 

  40. American Cancer Society:Cancer Facts and Figures—1997. Atlanta, GA: American Cancer Society, 1997.

    Google Scholar 

  41. Middleton RG, Thompson IM, Austenfeld MS, et al:Prostate Cancer Clinical Guidelines Panel: Report on the Management of Clinically Localized Prostate Cancer. Baltimore, MD: American Urological Association, Inc., 1995.

    Google Scholar 

  42. Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG: Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians.Annals of Internal Medicine. 1997,126:468–479.

    PubMed  CAS  Google Scholar 

  43. Screening for prostate cancer. American College of Physicians.Annals of Internal Medicine. 1997,126:480–484.

    Google Scholar 

  44. Optenberg SA, Thompson IM: Economics of screening for carcinoma of the prostate.Urological Clinics of North America. 1990,17:719–737.

    CAS  Google Scholar 

  45. Black WC, Welch HG: Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.New England Journal of Medicine. 1993,328:1237–1243.

    Article  PubMed  CAS  Google Scholar 

  46. American Cancer Society:Cancer Facts and Figures—1997. Atlanta, GA: American Cancer Society, 1997.

    Google Scholar 

  47. Eddy DM: Screening for breast cancer.Annals of Internal Medicine. 1989,111:389–399.

    PubMed  CAS  Google Scholar 

  48. Fletcher S: Breast cancer screening in women aged under 50 [Editorial].British Medical Journal. 1997,314:764–765.

    PubMed  CAS  Google Scholar 

  49. Fletcher SW: Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening.New England Journal of Medicine. 1997,336:1180–1183.

    Article  PubMed  CAS  Google Scholar 

  50. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998.Ca: A Cancer Journal for Clinicians. 1998,48(1):6–29.

    Article  CAS  Google Scholar 

  51. Benson MC, Whang IS, Pantuck A, et al: Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer.Journal of Urology. 1992,147:815–816.

    PubMed  CAS  Google Scholar 

  52. Catalona WJ, Smith DS, Wolfert RL, et al: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.Journal of the American Medical Association. 1995,274:1214–1220.

    Article  PubMed  CAS  Google Scholar 

  53. Kaplan RM: Breast cancer screening: When to begin? In Blechman EA, Brownell KD (eds),Behavioral Medicine and Women: A Comprehensive Handbook. New York: Guilford Publications 1998, 213–220.

    Google Scholar 

  54. Black WC, Welch HG: Screening for disease.American Journal of Roentgenology. 1997,168:3–11.

    PubMed  CAS  Google Scholar 

  55. Fowler FJ, Barry MJ, Lu-Yao G, et al: Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988–1990 (updated June 1993).Urology. 1993,42:622–629.

    Article  PubMed  Google Scholar 

  56. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team.Journal of the American Medical Association. 1993,269:2650–2658.

    Article  PubMed  CAS  Google Scholar 

  57. Krahn MD, Mahoney JE, Eckman MH, et al: Screening for prostate cancer. A decision analytic view.Journal of the American Medical Association. 1994,272:773–780.

    Article  PubMed  CAS  Google Scholar 

  58. National Institutes of Health Consensus Development Conference Statement: Breast Cancer screening for women ages 40–49, January 21–23, 1997. National Institutes of Health Consensus Development Panel.Journal of the National Cancer Institute. 1997,89(14):1015–1026.

    Article  Google Scholar 

  59. Col NF, Eckman MH, Karas RH, et al: Patient-specific decisions about hormone replacement therapy in postmenopausal women.Journal of the American Medical Association. 1997,277:1140–1147.

    Article  PubMed  CAS  Google Scholar 

  60. Winawer SJ, Fletcher RH, Miller L, et al: Colorectal cancer screening: Clinical guidelines and rationale.Gastroenterology. 1997,112:594–642.

    Article  PubMed  CAS  Google Scholar 

  61. von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N: American Cancer Society guidelines for the early detection of prostate cancer.Cancer. 1997,80(9):1805–1807.

    Article  Google Scholar 

  62. McNeil BJ, Pauker SG, Sox HC, Tversky A: On the elicitation of preferences for alternative therapies.New England Journal of Medicine. 1982,306:1259–1262.

    PubMed  CAS  Google Scholar 

  63. McNeil BJ, Weichselbaum R, Pauker SG: Fallacy of the five-year survival in lung cancer.New England Journal of Medicine. 1978,299:1397–1401.

    PubMed  CAS  Google Scholar 

  64. McNeil BJ, Weichselbaum R, Pauker SG: Speech and survival: Tradeoffs between quality and quantity of life in laryngeal cancer.New England Journal of Medicine. 1981,305:982–987.

    PubMed  CAS  Google Scholar 

  65. Eddy DM: Clinical decision-making: From theory to practice. The individual vs. society. Resolving the conflict.Journal of the American Medical Association. 1991,265:2399–2401, 2405–2406.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Presidential Address: Society of Behavioral Medicine, San Francisco, CA, April 1997.

Preparation of this manuscript was supported in part by a Scholars Grant from the American Cancer Society and Grant RO1 HS 09170 from the Agency for Health Care Policy and Research.

About this article

Cite this article

Kaplan, R.M. Shared medical decision-making: A new paradigm for behavioral medicine—1997 presidential address. ann. behav. med. 21, 3–11 (1999). https://doi.org/10.1007/BF02895027

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02895027

Keywords

Navigation